(Q36768269)

16 August 2017

1 reference

title

Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients (English)

1 reference

16 August 2017

1 reference

1 reference

Rhonda S Rea

1

1 reference

16 August 2017

Sarah Battistone

series ordinal

2

1 reference

16 August 2017

Jeffrey J Fong

series ordinal

3

1 reference

16 August 2017

John W Devlin

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

27

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

588-594

1 reference

Delirium in older persons

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Cognitive impairment in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

The impact of delirium in the intensive care unit on hospital length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Costs associated with delirium in mechanically ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Science is revolutionizing our view of addiction--and what to do about it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Hyperactivity in the hypothalamic-pituitary-adrenal axis in demented patients with delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Torsades de Pointes associated with intravenous haloperidol in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Treatment of delirium in older adults with quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

An open pilot trial of olanzapine for delirium in the Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Intensive care unit sedation: waking up clinicians to the gap between research and practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

A double-blind trial of risperidone and haloperidol for the treatment of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Olanzapine vs haloperidol: treating delirium in a critical care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Treatment of Delirium With Quetiapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Atypical antipsychotics: Part II: Adverse effects, drug interactions, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Tolerability of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Safety and tolerability: how do newer generation "atypical" antipsychotics compare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Effects of newer antipsychotics on extrapyramidal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Atypical antipsychotics in the management of delirium: a review of the empirical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Pharmacokinetic comparison of fast-disintegrating and conventional tablet formulations of risperidone in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Detection of delirium by bedside nurses using the confusion assessment method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

Large-scale implementation of sedation and delirium monitoring in the intensive care unit: a report from two medical centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.27.4.588

21 January 2018

Identifiers

DOI

10.1592/PHCO.27.4.588

1 reference

16 August 2017

1 reference